Literature DB >> 9413663

Steroid-sparing alternative treatments for sarcoidosis.

R P Baughman1, E E Lower.   

Abstract

Alternatives to corticosteroids for the treatment of sarcoidosis are reviewed. These include cytotoxic agents such as methotrexate, azathioprine, and cyclophosphamide. In addition, agents such as hydroxychloroquine and cyclosporine are reviewed. The efficacy, toxicity, and timing of these drugs in the management of sarcoidosis is discussed.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9413663     DOI： 10.1016/s0272-5231(05)70423-8

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN： 0272-5231            Impact factor:   2.878


  12 in total

Review 1.  A clinical approach to the use of methotrexate for sarcoidosis.

Authors:  R P Baughman; E E Lower
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Granulomatous Liver Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

Review 3.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

4.  Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease.

Authors:  Lisa A Maier; Briana Q Barkes; Margaret Mroz; Milton D Rossman; Juliana Barnard; May Gillespie; Allison Martin; Douglas G Mack; Lori Silveira; Richard T Sawyer; Lee S Newman; Andrew P Fontenot
Journal:  Respir Med       Date:  2012-09-11       Impact factor: 3.415

5.  Cutaneous Sarcoidosis: Report of Two Cases.

Authors:  S Grover; P S Murthy; P K Kar; V Tewari; T C Shivyogi; R Manjunath
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 6.  Sarcoidosis: a rheumatologist's perspective.

Authors:  Senol Kobak
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

Review 7.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

Review 8.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

Review 9.  Evidence-based therapy for cutaneous sarcoidosis.

Authors:  Christy B Doherty; Ted Rosen
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  [Granulomatous lung and systemic diseases].

Authors:  A Prasse; G Kayser; J Müller-Quernheim
Journal:  Internist (Berl)       Date:  2013-04       Impact factor: 0.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.